Nippon Chemiphar Co., Ltd. (TSE: 4539)
Health Care · Pharmaceuticals · JP
¥1,568.00
-1.01% today · -2.7% 1Y
Nippon Chemiphar Co., Ltd. (TSE: 4539) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $35.74M and employs 878 people.
Over the last twelve months the share price has lost 2.7%, trading between 1.50K and 1.86K.
Tweenvest scores Nippon Chemiphar Co., Ltd. across four factors: quality 63/100, value 46/100, growth 0/100, dividend 76/100. Its strongest factor is dividend.
4539 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $35.74M
- Revenue (TTM)
- $203.14M
- P/E
- —
- EPS
- -34.28
- Dividend yield
- 3.19%
- Beta (5Y)
- 0.19
- 52-week high
- ¥1,857.00
- 52-week low
- ¥1,502.00
- Avg volume (3M)
- —
- Shares outstanding
- 3.62M
- Employees
- 878
- Next earnings
- —
About Nippon Chemiphar Co., Ltd.
Nippon Chemiphar Co., Ltd., alongside its subsidiaries, is a global pharmaceutical entity engaged in the research, production, marketing, and sale of ethical drugs and diagnostic agents. Its diagnostic product lineup features the IgE NC kit, which measures overall IgE levels and identifies 57 specific allergens, as well as the DP3000 device for accurate allergen-specific IgE testing. The company's development pipeline includes NC-2400, a PPAR-delta agonist; NC-2500, a novel xanthine oxidoreductase inhibitor targeting hyperuricemia and gout; and NC-2600, a P2X4 receptor antagonist for neuropathic pain. Additionally, it is advancing NC-2700, a new urate transporter 1 inhibitor designed to enhance urinary urate excretion, and NC-2800, a delta opioid receptor agonist for treating depression and anxiety. Its commercialized pharmaceuticals comprise Uralyt-U (an alkalization therapeutic), Soleton (an analgesic and anti-inflammatory medication), and Calvan (a drug for hypertension). Beyond pharmaceuticals, Nippon Chemiphar offers a variety of quasi-drugs, nutritional supplements, health foods, cosmetics, and different types of creams. Its generic medications reach hospitals and pharmacies via wholesale distributors. Founded in Tokyo, Japan, in 1950, the company was initially known as Hitachi Chemical Co., Ltd., changing its name to Nippon Chemiphar Co., Ltd. in 1970.
- ISIN
- JP3701600003
- Founded
- 1950
- Listed since
- Jan 1, 2001
- Exchange
- The Tokyo Stock Exchange
- Currency
- JPY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,233.66 | -1.06% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $273.14 | +0.04% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $156.45 | +3.84% |
| Roche Holding AGSWX: ROP | $371.62B | CHF373.80 | +0.92% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £124.76 | +3.02% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.57 | +2.15% |
Figures last refreshed Aug 18, 2026.